I think the lack of progress reports plus your observations from Nearmap means that they are behind schedule to complete B2 and M2 in the second half of FY17. Looks like B2 is substantially ahead of M2 which is probably OK as Brisbane is a smaller and a less active market and M1 still has a bit of capacity. So hopefully revenue growth will not be substantially affected.
- Forums
- ASX - By Stock
- Thoughts..
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

I think the lack of progress reports plus your observations from...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14695 | 14.190 |
4 | 10094 | 14.180 |
1 | 2695 | 14.170 |
4 | 9059 | 14.160 |
1 | 2969 | 14.150 |
Price($) | Vol. | No. |
---|---|---|
14.280 | 100 | 1 |
14.290 | 5808 | 1 |
14.310 | 7418 | 5 |
14.330 | 5808 | 1 |
14.350 | 5808 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online